Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
clinical trials
5
×
immunotherapy
5
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
novartis
abeona therapeutics
acute myeloid leukemia
aimmune therapeutics
akcea therapeutics
amgen
autoimmune diseases
biotech ipos
cancer drugs
What
roundup
bio
biotech
days
drug
market
new
abbvie’s
according
advantages
agency
ahead
aimmune
akcea
allergy
approval
approved
arrival
awarded
bar
biofourmis
brings
bucks
cancer
cases
celebrate
centers
chance
cigarettes
companies
control
corner
day
deaths
developed
disease
electronic
expect
fda
forward
Language
unset
5
×
Current search:
immunotherapy
×
unset
×
biotech
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone